NCT06273072View on ClinicalTrials.gov

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 9, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2028

Conditions
AsthmaAsthma ChronicOverweight and Obesity
Interventions
DRUG

Metformin hydrochloride extended-release tablets

titrated to 2000 mg once daily

DRUG

Visually identical placebo Metformin hydrochloride extended-release tablets

placebo

Trial Locations (2)

21224

RECRUITING

Johns Hopkins University, Baltimore

77030

RECRUITING

Baylor College of Medicine, Houston

All Listed Sponsors
collaborator

Baylor College of Medicine

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Temple University

OTHER

lead

Johns Hopkins University

OTHER